<DOC>
	<DOC>NCT01584726</DOC>
	<brief_summary>The purpose of this study is to investigate the use of magnesium sulfate nebulization in patient with moderate to severe asthma exacerbation in pediatric emergency.</brief_summary>
	<brief_title>Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma</brief_title>
	<detailed_description>the use of magnesium sulfate nebulization in patient with moderate to severe asthma exacerbation in pediatric emergency follow asthma severity score and length of stay</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<criteria>Pediatric asthma patients with moderate to severe exacerbation Known allergy to magnesium sulfate History of neuromuscular disease, cardiac disease, renal disease, or underlying chronic lung disease Use of oral steroid medication within 72 hours of presentation Radiographic evidence of pneumonia at presentation Administration of intravenous magnesium sulfate prior to study enrollment</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>magnesium</keyword>
	<keyword>nebulization</keyword>
	<keyword>asthma</keyword>
	<keyword>sulfate</keyword>
	<keyword>children</keyword>
	<keyword>pediatric</keyword>
</DOC>